Kirk G. Downing

China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China.

The Brookings Institution provides research and policy solutions. The firm's activities are carried out through four research programs: economic studies, foreign policy studies, governance studies, and metropolitan policy. The company was founded in 1916 and is headquartered in Washington, DC.

Financial Services Development Council operates as a financial centre. The firm provides information of the FSDC’s activities in relation to the Hong Kong financial services industry, but also the FSDC’s publications on a wide spectrum of topics related to the industry such as the reports on mandatory provident fund system, life insurance as well as Environmental, Social and Governance (ESG).The company is headquartered in Hong Kong.

X-Tech Advisors Ltd. is an independent venture capital firm founded in 2016 by Nan Peng Shen. The firm is headquartered in Hong Kong.

Asia Society is an educational organization that aims to promote mutual understanding and strengthen partnerships among people, leaders, and institutions. The non-profit company is based in New York, NY and has subsidiaries in Hong Kong. The company was founded by Tom W. Su and Luis Juan L. Virata.

Focus Media Holding Ltd. offers digital media network services. It also offers commercial location media, in-store media, LCD display network, movie theater advertising and poster frame network services. The company was founded by Nan Chun Jiang in May 2003 and is headquartered in Shanghai, China.

Home Inns & Hotels Management (Hong Kong) Ltd. develops, operates and manages hotel chains under Home Inn brand. It also leases and franchise hotels. The company was founded in 2001 and is headquartered Hong Kong, Hong Kong

Part of Deutsche Bank AG, Deutsche Bank AG (Hong Kong) is a financial institution that has been connecting worlds for 65 years. The company is based in Hong Kong, Hong Kong, and serves as the hub for corporate and commercial clients. The company's asset management division, DWS, is a market leader in Hong Kong with a broad product offering. Its corporate bank division is an established market leader in transaction banking, with a presence in 60 countries, including an extensive footprint in HK. The investment bank provides strategic advice to corporate and institutional clients, focusing on the bank’s traditional strengths in financing, advisory, fixed income, and currencies, together with a focused equity capital markets business. The private bank focuses on private customers across all segments as well as business clients, and in HK, this division is represented by a highly competitive wealth manager. The Chinese company was founded in 1958, and its CEO is Werner Steinmüller.

Future Forum is a research consortium founded by Slack in partnership with Boston Consulting Group, Millerknoll, and Management Leadership for Tomorrow. The private company is based in Beijing, China. The Chinese company is dedicated to building a way of working that is flexible, inclusive, and connected. Future Forum enables leaders to reimagine work through data and executive insights and dialogue. The company also sponsors the Future Science Award, which focuses on original basic scientific research and rewards scientists in mainland China, Hong Kong, Macao, and Taiwan.

Ninebot Ltd. engages in the research, development, manufacture, and sales of self-balancing mobility devices, including: KickScooter, E-Skates, mobile photo robot, Segway hands-free two-wheel electric vehicle, Ninebot high-handle bar transporter. Its products are used as personal transportation tools focusing on environmental, fashionable, convenient, and short distance. The company was co-founded by Mr. Gao Lu Feng and Mr. Wang Ye on 2012 and is headquartered in Beijing, China.

Hero Entertainment Co., Ltd. engages in Internet entertainment business. It promotes mobile electronic games, develops online sports matrix, and provides mobile game contents and experience to overseas and domestic users. The company was founded on September 26, 2001 and is headquartered in Beijing, China.

Tyco International (US), Inc. engages in the provision of security, fire protection, and detection products and services. The company is headquartered in Exeter, NH.

Tyco Fire & Security LLC provides electronic security and fire protection solutions. The firm designs, manufactures, and installs detection and suppression systems, sprinklers, and fire extinguishers. It offers security solutions such as intrusion detection, access control, electronic article surveillance, and retail security management systems. The company was founded in 1997 and is headquartered in Boca Raton, FL.

Chenyi Fund Management Beijing Co., Ltd. engages in the equity investment management. The company was founded on August 8, 2019 and is headquartered in Beijing, China.

Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then.